Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Anti-varicella-zoster virus bicyclic nucleosides: Synthesis and in vitro evaluation of 2 ',3 '-dideoxy nucleoside derivatives — Antonella Carangio (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Anti-varicella-zoster virus bicyclic nucleosides: Synthesis and in vitro evaluation of 2 ',3 '-dideoxy nucleoside derivatives
Shared by
De Clercq Erik
KU Leuven
Anti-varicella-zoster virus bicyclic nucleosides: Synthesis and in vitro evaluation of 2 ',3 '-dideoxy nucleoside derivatives
Article
2002
en
Authors
+3 more
AC
Antonella Carangio
CM
Christopher McGuigan
GA
Graciela Andreï
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2003
Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus: Synthesis and Biological Evaluation of 2′,3′-Dideoxy- 3′-fluoro and 2′-Deoxy-xylo Derivatives
Antonella Carangio
,
Christopher McGuigan
,
Graciela Andreï
,
Robert Snoeck
,
De Clercq Erik
,
Jan Balzarini
Article
2004
Bicyclic Nucleoside Inhibitors of Varicella—Zoster Virus: Synthesis and Biological Evaluation of 2′,3′‐Dideoxy‐3′‐fluoro and 2′‐Deoxy‐xylo Derivatives
Antonella Carangio
,
Christopher McGuigan
,
Graciela Andreï
,
Robert Snoeck
,
De Clercq Erik
,
Jan Balzarini
Article
2001
SYNTHESIS AND IN VITRO EVALUATION OF NOVEL ANTI-VARICELLA-ZOSTER VIRUS (VZV) NUCLEOSIDES
Antonella Carangio
,
Christopher McGuigan
,
Dominique Cahard
,
Graciela Andreï
,
Robert Snoeck
,
De Clercq Erik
,
Jan Balzarini
Article
2001
ChemInform Abstract: Synthesis and in vitro Evaluation of Novel anti‐Varicella‐Zoster Virus (VZV) Nucleosides
Antonella Carangio
,
Christopher McGuigan
,
Dominique Cahard
,
Graciela Andreï
,
Robert Snoeck
,
De Clercq Erik
,
Jan Balzarini
Article
2003
Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus: 5′-Chloro and 3′-Chloro Derivatives
G Luoni
,
Christopher McGuigan
,
Graciela Andreï
,
Robert Snoeck
,
De Clercq Erik
,
Jan Balzarini
Discussion(0)
No comments yet. Be the first to comment.